Behcet's disease in patients with chronic myelogenous leukemia: Possible role of interferon-alpha treatment in the occurrence of Behcet's symptoms

Annals of Hematology

Volumn 74, Issue 1, 1997, Pages 45-48

  Budak Alpdogan T ^a   Demircay Z ^a   Alpdogan, O ^a   Direskeneli, H ^a   Ergun, T ^a   Bayik, M ^a   Akoglu, T ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Adverse effect; Alpha interferon; Behcet's disease; Chronic myelogenous leukemia; Pathergy reaction

Indexed keywords

ALPHA INTERFERON; CORTICOSTEROID; CYTARABINE; DAUNORUBICIN; TIOGUANINE;

ADULT; ARTHRALGIA; ARTHRITIS; ARTICLE; BEHCET DISEASE; BRAIN PSEUDOTUMOR; CASE REPORT; CHRONIC MYELOID LEUKEMIA; DIARRHEA; FEMALE; FEVER; FOLLICULITIS; GENITAL ULCER; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; MALE; MOUTH ULCER; MULTIPLE MYELOMA; MYALGIA; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; SKIN MANIFESTATION; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PHYSIOLOGY;

ADULT; BEHCET SYNDROME; FEMALE; HUMANS; INTERFERON-ALPHA; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED;

EID: 0030614596     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050255     Document Type: Article

References (15)

1. Talpaz M, Kantarjian H, McCredie K, Trujillo J, Keating M, Gutterman J (1986) Hematologic remission and cylogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia. N Engl J Med 314:1065-1070
2. Akard LP, Hoffman R, Elias L, Saiers JH (1986) Alpha-interferon and immune hemolytic anemia. Ann Intern Med 105:306
3. Quesada JR, Talpaz M, Dios A, Kurzrock R, Gutterman U (1986) Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 4:234-243
4. Schilling PJ, Kurzsock R, Kantarjian H, Gutterman JU, Talpaz M (1991) Development of systemic lupus erythematosus after interferon therapy for chronic myelogenous leukemia. Cancer 68:1536-1537
5. Conlon KC, Urba WJ, Smith JW Jr, Steis RG, Longo DL, Clark JW (1990) Exacerbation of symptoms of autoimmune disease in patients receiving alpha-interferon therapy. Cancer 65:2237-2242
6. Segawa F, Shimizu Y, Saito E, Kinoshita M (1995) Behçet's disease induced by interferon therapy for chronic myelogenous leukemia. J Rheum 22:1183-1184
7. Dilşen N, Koniçe M, Aral O, Öcal L, Inanç M, Gül A (1993) Comparative study of the skin pathergy test with blunt and sharp needles in Behçet's disease: confirmed specificity but decreased sensitivity with sharp needles. Ann Rheum Dis 52:823-825
8. International Study Group for Behçet's Disease (1990) Criteria for diagnosis of Behçet's disease. Lancet 335:1078-1080
9. Tassies D, Cervantes F, Feliu E, Cabal G, Martinez-Orozco F, Rozman C (1992) Enfermedad de Behçet de inicio previo a la aparicion de leucemia mieloide cronica. Med Clin 99:67-68
10. Akoglu T, Direskeneli H, Yazici H, Lawrence R (1990) TNF, soluble IL-2R and sCD8 in Behçet's Disease. J Rheum 17:1107-1108
11. Emmi L, Salvati G, Brugnolo F, Marchione T (1995) Immunopathological aspects of Behçet's disease. Clin Exp Rheum 13:687-691
12. Şahin-Özgün Ş, Akoǧlu T, Direskeneli H, Şen LS, Lawrence R (1996) Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. Ann Rheum Dis 55:128-133
13. Gordon MY, Dowding C, Riley G, Goldman JM, Greaves M (1987) Altered adhesive interactions with stroma of haematopoietic progenitor cells in chronic myeloid leukemia. Nature 328:342
14. Doweling C, Guo A-P, Osterholz J, Siczkowski M, Goldman J, Gordon M (1991) Interferon-α over-rides the deficient adhesion of chronic myeloid leukemia primitive progenitor cells to bone marrow stromal cells. Blood 78:499-505
15. Upadhyaya G, Cuba SC, Sih SA, Feinberg AP, Talpaz M, Kantarjian HM, Deisseroth AB, Emerson SG (1991) Interferon-α restores the deficient expression of the cytoadhesion molecule lymphocyte-function antigen-3 by chronic myelogenous leukemia progenitor cells. J Clin Invest 88:2131-2136